Inhibition of Proinflammatory Tumor Necrosis Factor-α-Induced Inducible Nitric-Oxide Synthase by Xanthine-Based 7-[2-[4-(2-Chlorobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-Nitrobenzene)piperazinyl]ethyl]-1, 3-dimethylxanthine (KMUP-3) in Rat Trachea: The Involvement of Soluble Guanylate Cyclase and Protein Kinase G
Authors:
- Chien-Wen ChenCCChien-Wen Chen
- Shu-Fen LiouSLShu-Fen Liou
- Jwu-Lai YehJYJwu-Lai Yeh
- Hui-Hsuan ChungHCHui-Hsuan Chung
- Ing-Jun ChenICIng-Jun Chen
- 1 September 2006
- journal article
- Published by Elsevier in Molecular Pharmacology
- Vol. 70 (3) , 977-985
Abstract
In the study of anti-proinflammation by 7-[2-[4-(2-chlorobenzene)piperazinyl] ethyl]-1,3-dimethylxanthine (KMUP-1) and 7-[2-[4-(4-nitrobenzene)piperazinyl]ethyl]-1,3-dimethylxanthine (KMUP-3), exposure of rat tracheal smooth muscle cells (TSMCs) to tumor necrosis factor-alpha (TNF-alpha), a proinflammatory cytokine, increased the expression of inducible nitric-oxide synthase (iNOS) and NO production and decreased the expression of soluble guanylate cyclase alpha1 (sGCalpha1), soluble guanylate cyclase beta1 (sGCbeta1), protein kinase G (PKG), and the release of cGMP in TSMCs. The cell-permeable cGMP analog 8-Br-cGMP, xanthine-based KMUP-1 and KMUP-3, and the phosphodiesterase 5 inhibitor zaprinast all inhibited TNF-alpha-induced increases of iNOS expression and NO levels and reversed TNF-alpha-induced decreases of sGCalpha1, sGCbeta1, and PKG expression. These results imply that cGMP enhancers could have anti-proinflammatory potential in TSMCs. TNF-alpha also increased protein kinase A (PKA) expression and cAMP levels, cyclooxygenase-2 (COX-2) expression, and activated productions of prostaglandin (PG) E2 and 6-keto-PGF1alpha (stable PGI2 metabolite). Dexamethasone and N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methane sulfonamide (NS-398; a selective COX-2 inhibitor) attenuated TNF-alpha-induced expression of COX-2 and activated productions PGE2 and PGI2. However, KMUP-1 and KMUP-3 did not affect COX-2 activities and did not further enhance cAMP levels in the presence of TNF-alpha. It is suggested that TNF-alpha-induced increases of PKA expression and cAMP levels are mediated by releasing PGE2 and PGI2, the activation products of COX-2. In conclusion, xanthine-based KMUP-1 and KMUP-3 inhibit TNF-alpha-induced expression of iNOS in TSMCs, involving the sGC/cGMP/PKG expression pathway but without the involvement of COX-2.Keywords
This publication has 39 references indexed in Scilit:
- Characterization of a Novel Type of Endogenous Activator of Soluble Guanylyl CyclaseJournal of Biological Chemistry, 2005
- Downregulation of cGMP-dependent protein kinase expression by inflammatory cytokines in vascular smooth muscle cellsAmerican Journal of Physiology-Cell Physiology, 2004
- Pharmacology of airway inflammation in asthma and COPDPulmonary Pharmacology & Therapeutics, 2003
- Role of Cyclooxygenase-2 in the Generation of Vasoactive Prostanoids in the Rat Pulmonary and Systemic Vascular BedsCirculation, 2003
- Selected Contribution: TNF-α modulates murine tracheal rings responsiveness to G-protein-coupled receptor agonists and KClJournal of Applied Physiology, 2003
- Phosphodiesterase 4 Inhibitors and the Treatment of AsthmaDrugs, 2000
- YC-1 Potentiates Nitric Oxide- and Carbon Monoxide-Induced Cyclic GMP Effects in Human PlateletsMolecular Pharmacology, 1998
- Cyclic GMP and cGMP-binding Phosphodiesterase Are Required for Interleukin-1-induced Nitric Oxide Synthesis in Human Articular ChondrocytesJournal of Biological Chemistry, 1998
- Mechanism of cytokine-induced modulation of beta-adrenoceptor responsiveness in airway smooth muscle.Journal of Clinical Investigation, 1996
- cGMP Upregulates Nitric Oxide Synthase Expression in Vascular Smooth Muscle CellsHypertension, 1995